MODULEX-GROUP
10.5.2021 09:02:09 CEST | Business Wire | Press release
Modulex Group announces today that current CEO Ketil M. Staalesen moves into a majority ownership role. This move, a long time in the making, will set Modulex up to achieve Staalesen’s goal of DKK 1 Billion in revenue and a Group EBITDA of 10%.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210510005057/en/
A native Norwegian, Ketil is a citizen of the world, having lived in several countries worldwide, including Denmark, Germany, Spain, UK, Mexico and the US. He completed his MBA at EBCM Barcelona/Munich.
“This week marks my 20th anniversary at Modulex. I grew up in this company professionally, and I can’t think of a more fitting week to move into a majority ownership position and take Modulex into a new era.”
Modulex, founded by the LEGO Group, has been a Denmark headquartered company since 1963. With offices and factories around the world, Modulex is a global leader in visual communication solutions. Their capabilities started in manufacturing and evolved into architectural signage, Design + Build solutions, global rebranding and recently launched a line up of green products in a continuing effort to offer sustainable solutions to clients.
“I feel a great responsibility to honour the Danish roots and the founder, Godtfred Kirk Christiansen’s vision for Modulex. The company has weathered significant change over the decades, and thanks to my incredible team and personal commitment from Peter Thorsen, our position is very strong. I have always felt incredible support from the team,” says Staalesen. Thorsen, a trusted mentor and business associate to Staalesen, will stay on a minority partner.
“The future of Modulex is in excellent hands,” says Peter Thorsen. “I have had the pleasure of working and mentoring Ketil for many years and see him develop into the leader Modulex needs. His vision, passion and his ability to bring an idea into action will bring Modulex to a new level.”
For more information, visit modulex.com or contact media@modulex.com .
About Modulex:
Founded in 1963 by the LEGO group, Modulex is a global leader in visual communication and brand implementation. Rooted in Danish design excellence and a modular signage concept, Modulex has evolved its offering with design, wayfinding, exterior custom solutions, and brand implementations on a local or global scale. In 2019 the ISO9001 certified factory in Denmark created a sustainable product line and had been awarded the Green Network diploma for nine straight years. The multi-national group has five factories globally. It has a presence in over 300 cities across 45 countries, giving them infinite reach and the ability to deliver on its promise of global vision, local reach, and one company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210510005057/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ThetaRay Named World’s Best Software Provider for AML and Sanctions Screening in the 2026 Euromoney Transaction Banking Awards5.11.2026 19:30:00 CET | Press release
Recognition caps standout year alongside ThetaRay’s Top 10 (#8) ranking in the 2026 Chartis Financial Crime and Compliance50 (FCC50) and category win for Explainable AI. ThetaRay, a global leader in AI-native financial crime compliance infrastructure, has been named The World’s Best Software Provider for AML and Sanctions Screening at the 2026 Euromoney Transaction Banking Awards. Evaluated by Euromoney’s editorial and research team, ThetaRay was recognized for technology excellence, verifiable performance, and advancing the modern transaction banking value chain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105714764/en/ The recognition reinforces ThetaRay’s standing as foundational compliance infrastructure for global institutions, closely following Chartis Research ranking ThetaRay #8 globally in the Financial Crime and Compliance50 (FCC50) 2026 report and naming the company a Category Winner for Explainable AI. “Our
Arthur D. Little: H1 2026 Private Capital Fundraising Strengthens While Market Sentiment Highlights Investor Shift to Europe over US and Asia5.11.2026 18:58:00 CET | Press release
H1 fundraising up 6% year-on-year as 43% of LPs see geopolitical volatility favouring European funds AI usage dominates industry attention, defence leads target investment themes Invest Europe, the association representing Europe’s private equity, venture capital and infrastructure sectors, as well as their investors, today released ‘Investing in Europe: Private Equity Activity H1 2026’ and ‘The Insight: State of the European Private Equity Industry 2026’, an annual market sentiment report published jointly with global management consultancy Arthur D. Little (ADL). Together, these show increased fundraising for European private equity and venture capital versus the same period last year, stronger investor allocation expectations for Europe, and declining appetite for the US and Asia. The sentiment report also demonstrates how AI is reshaping the industry and portfolio companies, while defence-related themes are topping GPs’ target investments. GPs (General Partners/fund managers of PE
Angelalign Appoints Marco Gadola as Senior Advisor5.11.2026 18:35:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel”) http://www.angelaligner.com, a global clear aligner leader, today announced that Marco Gadola has joined Angel as Senior Advisor. In this role, Marco will advise the Board and senior management on culture, strategy and governance. Marco, who has held many leadership positions, is well-known as a former CEO of Straumann Group, a leading global medical device company focused on dentistry. Marco said he is excited to join Angel. “I’ve followed Angel for 10 years and have seen how it has evolved,” he said, “It’s grown from a regional leader in innovative clinical solutions and high-quality products, to a worldwide organization trusted by orthodontic specialists, with an impressive innovation pipeline.” Fox Hu, CEO of Angel, said: “Angel has strong core capabilities, but we must continue to improve to serve orthodontists even better. We welcome Marco as an advocate for our customers and employees around the world and to help us build an outstan
Boomi Named a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms5.11.2026 17:25:00 CET | Press release
Boomi governs agents, with flexibility across cloud, hybrid, and fully on-premises deployments behind the firewall. Boomi, the data activation company for AI, today announced it has been recognized as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms. Boomi delivers agent management capabilities through the Agent Control Plane. Boomi believes this placement reflects its approach to solving one of the biggest hurdles in turning AI into ROI, by providing critical AI infrastructure that connects, governs, and controls AI costs across agents and skills from native and third-party providers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105515847/en/ Boomi Named a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms Key Takeaways Boomi has been recognized as a Visionary in the 2026 Gartner® Magic Quadrant™ for AI Agent Management Platforms. A complimentary copy of t
Biocodex Invests €15 Million in a New Industrial Platform for Live Biotherapeutic Products5.11.2026 16:04:00 CET | Press release
Biocodex, an independent French pharmaceutical company, announces a €15 million investment to develop an industrial platform in Beauvais, France, dedicated to Live Biotherapeutic Products (LBPs) derived from the microbiome. Building on more than 70 years of expertise in living microorganisms, microbiota, fermentation and pharmaceutical manufacturing, Biocodex aims to support its partners and, ultimately, its own programs, from research through to clinical and commercial production. The project aims to strengthen healthcare and industrial sovereignty in the field of next-generation microbiome-based therapies. Scientific advances in microbiome science are opening up new therapeutic perspectives, notably in oncology, inflammatory bowel diseases, certain rare diseases and women’s health. Moving from research to pharmaceutical production requires facilities adapted to living microorganisms and pharmaceutical requirements. Open to biotechnology companies worldwide, it will support LBP progra
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
